Can transforming growth factor beta and downstream signalers distinguish bicuspid aortic valve patients susceptible for future aortic complications?

Elsevier

Available online 18 November 2022, 107498

Cardiovascular PathologyAbstract

Patients with a bicuspid aortic valve have an extreme high risk to develop a thoracic aortic aneurysm and dissection (TAAD). TAADs form a leading cause of death worldwide, with the majority of deaths being preventable if individuals at risk are identified and properly managed. Risk stratification for TAADs in bicuspidy is so far solely based on the aortic diameter. Exclusive use of aortic wall dimension, as in the current guidelines, is however not sufficient in selecting patients vulnerable for future aortic wall complications. Moreover, there are no effective medical treatments for TAADs to retain progressive aortic dilatation and thus prevent or delay aortic complications. Only surgical replacement of the aorta increases life expectancy in patients with a risk for a TAAD. Therefore, the next major challenge in the management of TAADs is the development of a personalized patient-tailored risk stratification for early detection of patients with an increased risk for TAADs, who will benefit from surgical resection of the aorta. Several signaling pathways have been studied in recent times to develop a patient specific risk stratification model. In this paper we discuss TGF-β signaling and downstream signalers as potential markers for future aortic complications in bicuspid aortic valve patients.

Section snippetsDeclaration of Competing Interest

none

References (14)TM Sequeira Gross et al.Comparison of microstructural alterations in the proximal aorta between aortic stenosis and regurgitation

The Journal of thoracic and cardiovascular surgery

(2021)

J Jiao et al.Differentiation defect in neural crest-derived smooth muscle cells in patients with aortopathy associated with bicuspid aortic valves

EBioMedicine

(2016)

N Grewal et al.Normal and abnormal development of the aortic valve and ascending aortic wall: a comprehensive overview of the embryology and pathology of the bicuspid aortic valve

Annals of cardiothoracic surgery

(2022)

N Grewal et al.A Systematic Histopathologic Evaluation of Type-A Aortic Dissections Implies a Uniform Multiple-Hit Causation

Journal of cardiovascular development and disease

(2021)

N Grewal et al.Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?

Heart and vessels

(2016)

N Grewal et al.Aortopathy in bicuspid aortic valve and marfan syndrome is characterized by a lack of activation potential of the epicardium in the ascending aorta

International Journal of Pathology and Clinical Research

(2017)

C Rueda-Martínez et al.Increased blood levels of transforming growth factor β in patients with aortic dilatation

Interactive cardiovascular and thoracic surgery

(2017)

There are more references available in the full text version of this article.

View full text

© 2022 Elsevier Inc. All rights reserved.

留言 (0)

沒有登入
gif